Secrecy

How to Cool Down Global Warming

Drawing on documents obtained through the Freedom of Information Act, Rolling Stone details the Bush administration's "ongoing strategy to block federal action on global warming." In 2002, the administration's Climate Action Report was reported on as a "stark shift" in U.S. policy.

No

Disclosure May Derail Doctors' Gravy Train

Medicines Australia, the drug industry's peak lobby group, has lost a legal bid to protect member companies from being required to disclose details of hospitality they provide at "educational" events for doctors.

No

The "Family Jewels" Show: The More Things Change...

On June 25, the Central Intelligence Agency will declassify its "full 693-page file amassed on CIA's illegal activities by order of then-CIA director James Schlesinger in 1973 -- the so-called 'family jewels.'" The non-governmental research institute National Security Archive "separately obtained ...

No

Military PR To Recruit Bodies, Hearts and Minds

"Army Strong, as the Army's latest recruiting campaign is called ... has a definite emphasis on electronic communications, from opportunities to chat live on the Web site with soldiers ... to interactive sections showing what boot camp is like, the different specialties the Army trains people for, and more," writes PR Week.

No

Guest Blog: The Sunlight Foundation's Paul Blumenthal on Sen. Mitch McConnell & The Blocked Transparency Legislation

Managing Editor's note: This is a guest blog by Paul Blumenthal, one of SourceWatch's citizen editors and a staffer for the Sunlight Foundation who blogs at In Broad Daylight. It does not necessarily represent the views of the Center for Media and Democracy. We welcome all informative, quality submissions related to Congress and Congresspedia articles, regardless of the point of view.

FDA Rejects Sunlight

In the wake of the latest study showing heart attack risk in an FDA-approved drug, there have been increased calls for greater transparency of clinical trial results. What does the U.S. Food and Drug Administration think about requiring companies to publicly release all of their trial results?

No

Unhealthy Secrecy

The chairperson of the Best Medicines Coalition (BMC), Louise Binder, recently appeared before the Canadian parliament's health committee to argue the case for patients gaining access to newer and more expensive drugs. When asked who funded BMC, Binder told the committee that half its funding came from the government agency, Health Canada, and the remainder was from the drug industry.

No

Pages

Subscribe to Secrecy